Specifically, at MOI ratios of 3:1 and 10:1, the selective mPGES-1 inhibitor MF63 markedly reduced the SA113 infection-triggered elevation in IL-6 production (p < 0.001) (Figure 1(C2)). This evidence concerns the gene IL6 and infection.